@BioNxtSolutions profile picture
BioNxt Solutions @BioNxtSolutions

Medical solutions from innovation to impact.

Joined October 2020
  • Tweets 250
  • Following 49
  • Followers 190
123 Photos and videos
news | financial: Synlab, XPhyto, Novavax - How long will the Corona boom last? Read the whole article here: news.financial/comments/synl… German version: kapitalerhoehungen.de/kommen… $XPHY $XPHYF
10
XPhyto provides progress update on Psychedelic Medicine Programs and Novel Compounds Milestone Press release available in English and German here: xphyto.com/xphyto-provides-p… $XPHY $XPHYF
2
10
Researchanalyst.com: XPhyto consistently implements 3-pillar strategy — Market rewards efforts Read the whole article here: researchanalyst.com/en/updat… $XPHY $XPHYF
4
Researchanalyst.com: XPhyto Therapeutics - Three hot irons in the fire Get the whole research here: researchanalyst.com/en/repor… $XPHY $XPHYF
1
9
XPhyto Reports on its Three Primary Business Divisions Read the press release here: xphyto.com/xphyto-reports-on… $XPHY $XPHYF
3
8
news | financial: Novavax, XPhyto Therapeutics, Biontech, Valneva - The vaccine blockbusters are on the move again! Read the whole article here: news.financial/comments/nova… $XPHY $XPHYF

Novavax, XPhyto Therapeutics, BioNTech, Valneva - The vaccine blockbusters are on the move again!

It is on again with the vaccine producers. Experts consider the pandemic to be over by the summer of 2022, but vaccination rates are still low, and infection figures are rushing from record to...

news.financial
2
6
"How XPhyto Therapeutics could revolutionise PCR Testing." Read the article published by Health Europa in its latest issue of Health Europa Quarterly here: edition.pagesuite-profession… A German translation is available at: irw-press.com/de/news/health… $XPHY $XPHYF

Health Europa Quarterly

Health Europa Quarterly - H20

edition.pagesuite-professional.co.uk
6
XPhyto Executes Covid-ID Lab Sales Contracts with Test Clinics and Pharmacies in Germany as part of Multi-Product Rollout Strategy Read the press release here: xphyto.com/xphyto-executes-c… $XPHY $XPHYF
2
7
Tests still in high demand: @AbbottNews profit and sales beat estimates on vigorous #COVID test demand reuters.com/business/healthc…

Abbott profit, sales beat estimates on vigorous COVID test demand

Abbott Laboratories on Wednesday beat quarterly profit and sales estimates, aided by robust sales of COVID-19 test kits and strong demand for its diagnostics products, but forecast lower-than-expec...

reuters.com
1
5
XPhyto Provides Update on Integration of 3a-diagnostics GmbH Read the press release here: xphyto.com/xphyto-provides-u… $XPHY $XPHYF
7
#CBD inhibits #COVID. Science article published last week: science.org/doi/10.1126/scia… Inhibition of #SARS-CoV-2 replication is only possible when #THC is absent, so pure CBD is required. #XPhyto is just ready to go for a first clinical study with Vektor's CBD-ODF. $XPHY $XPHYF
2
10
"Fast PCR tests: Are they the solution?" The Stuttgarter Zeitung presents under this headline rapid on-site #PCR tests as a possible solution for the emerging test shortage. Read the article online (German, paid): stuttgarter-zeitung.de/inhal… $XPHY $XPHYF
4
9
XPhyto Announces Head of Sales, Europe Mr. Zdarek will focus on building out #distribution, #sales and #marketing, with high priority on the commercialization of Covid-ID Lab, the Company’s rapid RT-#PCR test. Read the press release here: xphyto.com/xphyto-announces-… $XPHY $XPHYF
1
11
XPhyto signs Distribution Agreement for Czech Republic, rollout planned for Hungary, Slovakia, Ukraine and Russia Read the press release here: xphyto.com/xphyto-signs-dist… $XPHY $XPHYF
2
6
XPhyto Announces New Director of Business Development and Head of Diagnostic Research Mr. Roland Spleiss joined as the Director of Business Development Dr. Heinrich Jehle joined as Head of Diagnostic Research. Read the press release here: xphyto.com/xphyto-announces-… $XPHY $XPHYF
1
7
XPhyto #Epilepsy #clinicaltrial planned in 2022 with its proprietary fast-dissolving CBD oral strips European human CBD bioavailability study will commence in January 2022. xphyto.com/xphyto-epilepsy-c… $XPHY $XPHYF
5
15
XPhyto Completes Strategic #Acquisition of 3a-diagnostics - Positioned as leading #Biosensor producer - Adds IP and scientific expertise - Gains technical and business synergies - Secures #infectious #disease biosensor portfolio xphyto.com/xphyto-completes-… $XPHY $XPHYF

1
2
11
We’re leading ground-breaking work in pharmaceuticals. From applying psychedelics to major neurological diseases to developing rapid testing to support pandemic management; our work is all about innovation to impact. Learn more about us here: bit.ly/3FuL4Sx $XPHY
1
2
12
XPhyto Therapeutics Closes Private Placements for Gross Proceeds of $7,000,0000 $XPHY $XPHYF

XPhyto Therapeutics - News Release

xphyto.com
2
15
As more people start to see the potential of psychedelics as a treatment for severe mental health concerns, investment in the innovative companies at the forefront continues to surge. Read the full @EPM_Magazine article here: bit.ly/3kRInD0 $XPHY
10
Load more